OQROGet OQRO Pro
Insider trade

Treace Medical Concepts (TMCI)CEO bought ~$22K

John T. Treace, CEO at Treace Medical Concepts, bought ~$22K of Treace Medical Concepts shares.

~$22K
Approx. value · 5,000 sh @ $4.35
7.39M
Holds after · shares reported
Traded
Aug 21, 2026
Filed
Aug 24, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 7, 2026Company filing · Form 8-K · ResultsReported its results
  2. Aug 20, 2026InsiderCEO purchased ~$177K of TMCI shares in the open market
  3. Aug 21, 2026 · this disclosureInsiderCEO purchased ~$22K of TMCI shares in the open market

What came next

  1. Aug 24, 2026InsiderCEO purchased ~$48K of TMCI shares in the open market
  2. Sep 15, 2026FDAFDA device clearance: TMC Implant Fixation System
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Treace Medical Concepts

For Treace Medical Concepts, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMCI page.

Other recent filings by John T. Treace, Chief Executive Officer

The full history of John T. Treace, Chief Executive Officer is on the profile page.

How this filing works

Explore the data

Other disclosures at Treace Medical Concepts

Everything OQRO holds on this company is on its TMCI page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data